newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cometriq, Nda #203756 (Labeling)

Approval Date: 10/09/2025; Drug Name: Cometriq, Nda #203756; Active Ingredients: CABOZANTINIB S-MALATE; Company: Exelixis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 203756

Company
EXELIXIS
Keywords
EXELIXIS